ABOS Acumen Pharma Yalpi foyda normasi

Acumen Pharmaceuticals Inc. (ABOS) kompaniyasining rasmiy ramzlari

GURU.Markets platformasi tomonidan hisobot berilgan yalpi savdo marjasi daromadlilik dinamikasini namoyish etadi, bunda 0.00 joriy metrika darajasini ifodalaydi. Acumen Pharmaceuticals (ABOS) ilmiy markazlar bilan hamkorlik orqali Altsgeymer kasalligi davolash vositalarini qidirishni jadallashtirmoqda. Nevrologlar orasidagi yuqori brend obro'si terapiyaning salohiyatini tasdiqlaydi. Biznesning moslashuvchanligi ishlab chiqarish va sinovlarni tashqi pudratchilarga autsorsing qilish orqali ta'minlanadi.

Acumen Pharmaceuticals (ABOS): Yalpi marja 04.07.2022dan 19.11.2026gacha

Acumen Pharmaceuticals Inc. (ABOS) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahlili:Acumen Pharmaceuticals
Acumen Pharmaceuticals, Inc. asosiy tovari

Acumen Pharmaceuticals (ABOS) Altsgeymer kasalligini davolash uchun maxsus antitanalarni ishlab chiqishga ixtisoslashgan bo'lib, uzoq muddatli bozor ustunligining poydevorini yaratmoqda. Valoviy marjan barqarorligining tahlili bevosita ishlab chiqarish xarajatlaridan tozalangan tushumlar ulushini baholash imkonini beradi, bu esa investorlarga tizimli biznes model samaradorligini bir martalik omillardan ajratishga va kompaniyaning fundamental barqarorligini aniqlashga yordam beradi.

Muhim raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)